90% of Irish parents worry about the products they use on their child’s skin – according to a new Oilatum Junior survey

  • While 80% of parents read the ingredients list when selecting skincare products for their children, nearly two thirds admitted they have limited or no understanding of the function of the ingredients listed on a product.
  • Two thirds of parents said that knowing their child’s skincare product was made in Ireland would positively affect their decision to buy.

 

90% of Irish parents worry about the products they use on their child’s skin according to a new survey on children’s skincare conducted by Oilatum Junior, the Irish-made skincare range for dry skin.

The survey was commissioned by GSK, the makers of Oilatum Junior as part of their ‘Take Comfort in Our Science’ campaign with over 1,100 parents taking part in the online poll. The campaign is aimed at educating parents about their childrens’ dry skin conditions and the importance of science when it comes to creating the right dermatologically based product for these conditions.

The findings show that 55% of children in this survey experienced dry skin while just over half of the children in this survey suffered from eczema. The impact of these conditions can be wide-ranging, with parents reporting symptoms such as physical discomfort, not being able to take part in physical activity and interrupted sleep. Emollient creams are the most popular product for treating these conditions, with over half of those questioned saying they find emollients most effective.

The survey shows that 80% of parents read the ingredients list when selecting skincare products for their children. Worryingly, almost a quarter of parents (23%) feel they have little understanding of the science behind treating skin conditions such as eczema and almost two thirds of parents admitted they have limited or no understanding of the function of the ingredients listed on a product.

76% of parents rely on their GP for advice about their child’s skincare condition and 60% have asked their pharmacist while 25% of parents admit to turning to online sources for advice and support.

Over 30% of parents have to distract their child while applying cream and some of the tactics used include cuddles, electronics, books, food and games. After bathtime is the most popular time for moisturizing (56%) whereas 12% of parents choose to moisturize their child’s skin a number of times a day.

Almost 90% of parents purchase skincare products in a pharmacy, with two thirds saying knowing their child skincare product was made in Ireland would affect their decision to buy.

Key themes also affecting parents decision to buy are, in order of importance, the products ingredients, an endorsement from a GP or pharmacist, credibility of the producer, research led science and endorsement from a celebrity.

Developed by scientists for regular use, Oilatum Junior Cream softens and hydrates the skin, creating a protective layer to prevent future dryness and helping to stop the cycle of dry, itchy skin. Dermatologically tested and suitable for babies even from one day old, Oilatum Junior Cream can be used on dry skin and is clinically tested to significantly reduce itching for up to 8 hours, providing long-lasting relief.

The survey results formed the basis of an information session on ‘Take Comfort in our Science’, held on Tuesday April 4th in Dublin. Russell Macpherson, GSK’s Director of New Product Introduction and Product Technology, spoke about the science behind Oilatum products which are manufactured at GSK’s dermatology site in Sligo. Key facts and figures of the survey results were discussed by Oilatum Junior nurse educator Eleanor Doherty, who also discussed the importance of moisturising children’s skin and gave a demonstration on how to apply skincare products to a child. A panel discussion followed, moderated by TV presenter and mum of three, Anna Daly.

Dr Russell Macpherson, GSK’s Director of New Product Introduction and Product Technology, says:

“We really wanted to focus on the science behind Oilatum as ultimately that is what helps makes Oilatum different. Our Sligo manufacturing site makes over 3.3 million Oilatum products every year for export all around the world, and we want to play our part in helping Irish parents understand the science behind their children’s dry skin and how Oilatum Junior helps. We also wanted to highlight formulations and products, like Oilatum Cream, that are ultimately so effective in treating dry/irritated skin and eczema. Hopefully today will have helped educate parents around the science behind this so they can effectively choose the most suitable product for their child.”

Oilatum Cream contains light liquid paraffin. Always read the label / leaflet.

 

About GSK in Ireland:

GSK, one of the world’s leading healthcare companies, employs 1,800 people across four locations in Ireland – Dungarvan, Cork, Sligo and Dublin. GSK is committed to helping people around the world to do more, feel better and live longer. GSK is challenging the status quo of how a healthcare company can contribute to global health through improving access and innovation through both what and how we operate.

GSK in Dungarvan which produces a variety of ‘over-the-counter’ pharmacy and oral care products is the global home of Panadol:  Around 7.5 billion Panadol tablets are produced in Dungarvan each year – that’s 150 Panadol tablets a second – exporting to over 70 countries worldwide.

Our Cork site produces the active ingredients for a range of medicines for diseases such as childhood cancer, depression, diabetes, HIV, Parkinson’s disease and arthritis while our Sligo facility is dedicated to skincare producing around 30 million skin medicines and products every year including Oilatum and Physiogel exporting to over 65 countries.

Our Dublin headquarters are home to our Pharmaceuticals and Consumer Healthcare businesses. Our Pharma business is a leader in respiratory medicines and the largest provider of vaccines to the HSE in Ireland while the consumer healthcare is one of the leaders in both the pain and oral care markets owning famous brands such as Panadol, Voltarol, Sensodyne and Corsodyl.